Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 351 | 530 | 241 | 122 | 1,117 |
| Gross Profit | 351 | 530 | 241 | 122 | 1,117 |
| Operating Expenses | 1,986 | 4,225 | 3,112 | 2,222 | 2,330 |
| Operating Income | -1,635 | -3,695 | -2,871 | -2,100 | -1,213 |
| Interest Expense | 1 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 2,500 | -3 | -1 |
| Pre-tax Income | -1,636 | -3,695 | -371 | -2,103 | -1,214 |
| Net Income Continuous | -1,636 | -3,695 | -371 | -1,981 | -1,214 |
| Net Income Discontinuous | -36 | 112 | -124 | N/A | N/A |
| Net Income | $-1,672 | $-3,583 | $-495 | $-1,913 | $-1,214 |
| EPS Basic Total Ops | -0.80 | -1.80 | -0.20 | -0.80 | -0.80 |
| EPS Basic Continuous Ops | -0.80 | -1.80 | -0.20 | -0.96 | -0.78 |
| EPS Basic Discontinuous Ops | -0.02 | 0.06 | -0.06 | N/A | N/A |
| EPS Diluted Total Ops | -0.80 | -1.80 | -0.20 | -0.80 | -0.80 |
| EPS Diluted Continuous Ops | -0.80 | -1.80 | -0.20 | -0.96 | -0.78 |
| EPS Diluted Discontinuous Ops | -0.02 | 0.06 | -0.06 | N/A | N/A |
| EBITDA(a) | $-1,580 | $-3,639 | $-2,804 | $-2,014 | $-1,125 |